Clinical trials: Stereotactic Body Radiation Therapy
Non-small Cell Lung Cancer Stage I, Surgery
Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer
The primary objective of this study is disease free survival rate at 5 years in stage IA2 (T1aN0M0 or T1bN0M0 only) non-small cell lung cancer (NSCLC) patients treated either by surgery or stereotactic body radiation therapy…
- Conditions
- Non-small Cell Lung Cancer Stage I, Surgery, Stereotactic Body Radiation Therapy
- Trial name
- RAXSIA (NCT03431415)
- Testing
- Anatomical Segmentectomy, Lobectomy or Bilobectomy, Stereotactic Body Radiation Therapy
- Where
- 2 sites in Canada
- Sponsor
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC
The purpose of this study is to determine whether stereotactic radiosurgery combination with Anlotinib could improve the efficacy and outcomes for non-small cell lung cancer with limited brain metastases.
- Trial name
- AnloSBRT (NCT04912128)
- Testing
- Anlotinib
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Peking University Third Hospital
Nasopharyngeal Carcinoma, Metastasis
SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma
Primary metastatic NPC patients received chemotherapy± immunotherapy, radiation for primary tumors and SBRT for metastatic lesions.
- Conditions
- Nasopharyngeal Carcinoma, Metastasis, Stereotactic Body Radiation Therapy
- Trial name
- NCT04351282
- Testing
- SBRT
- Where
- China
- Volunteers
- 43 people
- Sponsor
- Fudan University
Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC
The purpose of this study is to determine whether stereotactic radiosurgery combination with Anlotinib is safe, effective in the treatment of limited brain metastases with Perilesional edema in non-small cell lung cancer.
- Trial name
- Rvision-001 (NCT04147728)
- Testing
- Anlotinib, Stereotactic Radiosurgery
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Peking University Third Hospital
Esophageal Cancer, Metastatic Esophageal Cancer
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Patients with esophageal cancer that had metastatic lesions after been treated with definitive surgery or chemoradiotherapy are being asked to participate in this study. 1.
- Conditions
- Esophageal Cancer, Metastatic Esophageal Cancer, Stereotactic Body Radiation Therapy, Thymalfasin
- Trial name
- NCT02545751
- Testing
- Stereotactic Body Radiation Therapy, Thymalfasin
- Where
- China
- Volunteers
- 29 people
- Sponsor
- Hangzhou Cancer Hospital
Hepatocellular Cancer, Quality of Life
Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma
Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer.
- Conditions
- Hepatocellular Cancer, Quality of Life, Stereotactic Body Radiation Therapy, Observational
- Trial name
- LIVERCARE (NCT03253536)
- Testing
- observational
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Ludwig-Maximilians - University of Munich